GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 98 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,039,000 | -42.8% | 43,480 | -65.1% | 0.00% | 0.0% |
Q4 2020 | $1,818,000 | -2.4% | 124,532 | -5.0% | 0.00% | 0.0% |
Q3 2020 | $1,862,000 | -36.5% | 131,152 | -34.2% | 0.00% | -50.0% |
Q2 2020 | $2,933,000 | +3810.7% | 199,370 | +1172.0% | 0.00% | – |
Q4 2019 | $75,000 | -10.7% | 15,674 | +13.2% | 0.00% | – |
Q3 2019 | $84,000 | -58.0% | 13,849 | -49.0% | 0.00% | – |
Q3 2018 | $200,000 | +16.3% | 27,153 | +0.5% | 0.00% | – |
Q2 2018 | $172,000 | +31.3% | 27,007 | +12.5% | 0.00% | – |
Q1 2018 | $131,000 | +133.9% | 24,008 | +77.7% | 0.00% | – |
Q4 2017 | $56,000 | – | 13,512 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|